Pakka Limited: Monitoring Agency Report Q3FY26 Shows Deviation in Share Warrant Exercise Price
Pakka Limited's Q3FY26 Monitoring Agency Report indicates the preferential issue of equity shares is fully utilized. However, the share warrant exercise price (Rs. 204) is significantly higher than the current trading price (Rs. 93.60), posing a risk to objective viability. Project Jagriti's COD is extended to August 1, 2026, with a Rs. 67.89 crore cost overrun pending financial closure.
The concerns raised about warrant exercise price and project delays could affect investor confidence and future funding plans, thus having a medium impact on the company.
The report highlights a significant concern regarding the company's share price trading below the warrant exercise price, which could impact the viability of the objectives. Delays and cost overruns in Project Jagriti also contribute to negative sentiment.
Pakka Limited has submitted its Monitoring Agency Report for the 3rd quarter ended December 31, 2025, concerning the preferential issue of equity shares and fully convertible warrants. The report, issued by CARE Ratings Limited, details the utilization of proceeds raised through the preferential issue of 54,00,000 Equity Shares and 36,00,000 Fully Convertible Warrants.
The total preferential issue size was Rs. 244.80 crore, comprising Rs. 146.88 crore for equity shares and Rs. 97.92 crore for warrants. During Q3FY26, all proceeds from the preferential issue of equity shares were utilized as per objectives. However, only 25% of the share warrants' issue price was received upfront, with the remaining 75% due within 18 months from the allotment date (October 13, 2025).
The report highlights a significant concern: the company's share price (Rs. 93.60 as of January 28, 2026) is trading considerably below the warrant exercise price of Rs. 204. This discrepancy of ₹73.44 crore pending from warrant holders may impact the viability of the objectives, as subscribers might allow warrants to lapse. Additionally, the Commercial Operation Date (COD) for Project Jagriti has been extended to August 01, 2026, from April 01, 2026, with an estimated cost overrun of Rs. 67.89 crore, to be funded through debt and equity, although financial closure for this overrun is pending.
During H1FY26, Pakka Limited reported a revenue decline to Rs. 158.06 crore from Rs. 207.88 crore in H1FY25, primarily due to a plant shutdown for Project Jagriti's expansion. The company has obtained all requisite government and statutory approvals for its objectives. No funds were utilized for general corporate purposes during Q3FY26.
What to do with a filing like this
PAKKA LIMITED filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by PAKKA LIMITED. Read the original for the full detail.